Ask AI
ProCE Banner Activity

Selecting Patients to Receive Bridging Therapy Before CAR-T in R/R MM

Slideset

Downloadable slideset reviewing the rationale for bridging therapy prior to CAR T-cell treatment in R/R multiple myeloma, including supporting clinical data, in-depth patient cases to illustrate candidate selection, and practical clinical pearls addressing decision-making and ongoing challenges.

Released: December 29, 2025

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson

Target Audience

This activity has been designed to meet the educational needs of hematologists/oncologists and other healthcare professionals caring for patients with multiple myeloma who are likely to benefit from bridging therapy prior to CAR T-cell treatment. 

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Identify patients with multiple myeloma who are likely to benefit from bridging therapy prior to CAR T-cell treatment